Oxbridge Re (NASDAQ:OXBR) Downgraded to Strong Sell Rating by Zacks Research

Posted by on Aug 20th, 2026

Oxbridge Re (NASDAQ:OXBR – Get Free Report) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Tuesday,Zacks.com reports.

Several other equities research analysts have also commented on OXBR. Maxim Group cut their price target on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a report on Tuesday, June 16th. Weiss Ratings raised shares of Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a report on Friday, August 14th. One analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $3.00.

Check Out Our Latest Stock Analysis on OXBR

Oxbridge Re Trading Down 0.7%

Shares of OXBR opened at $1.34 on Tuesday. The firm has a market cap of $10.91 million, a P/E ratio of 67.03 and a beta of 1.94. Oxbridge Re has a 12 month low of $0.66 and a 12 month high of $2.86. The stock’s 50 day moving average is $1.31 and its two-hundred day moving average is $1.08.

Oxbridge Re (NASDAQ:OXBR – Get Free Report) last announced its earnings results on Thursday, August 13th. The insurance provider reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.01). Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%.The business had revenue of $0.94 million for the quarter, compared to analyst estimates of $1.10 million. Equities research analysts forecast that Oxbridge Re will post -0.08 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new stake in shares of Oxbridge Re during the third quarter worth $32,000. International Assets Investment Management LLC purchased a new position in shares of Oxbridge Re in the fourth quarter worth about $39,000. Finally, J.W. Cole Advisors Inc. lifted its stake in shares of Oxbridge Re by 106.1% in the fourth quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after buying an additional 35,000 shares in the last quarter. 5.64% of the stock is owned by institutional investors and hedge funds.

Oxbridge Re Company Profile

(Get Free Report)

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.

Read More

Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.